Rethinking agrochemical safety assessment: A perspective.

[1]  Jeffrey M. Minucci,et al.  Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment , 2021, Regulatory toxicology and pharmacology : RTP.

[2]  Ryan Weidling,et al.  Using existing knowledge for the risk evaluation of crop protection products in order to guide exposure driven data generation strategies and minimise unnecessary animal testing , 2021, Critical reviews in toxicology.

[3]  Sophie van der Kamp,et al.  Increasing Confidence in Waiving Dermal Toxicity Studies: A Comparison of Oral and Dermal Acute Data with Alternative Approaches for Agrochemicals and Products. , 2021, Regulatory toxicology and pharmacology : RTP.

[4]  R. Woutersen,et al.  Towards a mechanism-based approach for the prediction of nongenotoxic carcinogenic potential of agrochemicals , 2020, Critical reviews in toxicology.

[5]  G. Patlewicz,et al.  Derivation of New Threshold of Toxicological Concern Values for Exposure via Inhalation for Environmentally-Relevant Chemicals , 2020, Frontiers in Toxicology.

[6]  Nicola J Hewitt,et al.  A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals. , 2020, Regulatory toxicology and pharmacology : RTP.

[7]  S. Gehen,et al.  Letter to the editor regarding Heringa et al. (2020) paper entitled "use of the Kinetically-derived Maximum Dose concept in selection of top doses for toxicity studies hampers proper hazard assessment and risk management". , 2020, Regulatory toxicology and pharmacology : RTP.

[8]  A. Vinggaard,et al.  A novel human pluripotent stem cell-based assay to predict developmental toxicity , 2020, Archives of Toxicology.

[9]  A. Boobis,et al.  Use of the kinetically-derived maximum tolerated dose: Opportunities for delivering 3Rs benefits. , 2020, Regulatory toxicology and pharmacology : RTP.

[10]  Martin Paparella,et al.  Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens , 2020, Archives of Toxicology.

[11]  A. Prina‐Mello,et al.  In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective , 2020, Frontiers in Bioengineering and Biotechnology.

[12]  Marjolijn Woutersen,et al.  Use of the kinetically-derived maximum dose concept in selection of top doses for toxicity studies hampers proper hazard assessment and risk management. , 2020, Regulatory toxicology and pharmacology : RTP.

[13]  N. Cnubben,et al.  Regulating human safety: How dose selection in toxicity studies impacts human health hazard assessment and subsequent risk management options. , 2020, Regulatory toxicology and pharmacology : RTP.

[14]  A. Piersma,et al.  Predicting the Safety of Medicines in Pregnancy: a Workshop Report. , 2020, Reproductive toxicology.

[15]  D. Wolf,et al.  Implementing a Globally Harmonized Risk Assessment-Based Approach for Regulatory Decision-Making of Crop Protection Products. , 2020, Pest management science.

[16]  Anna Lowit,et al.  Reducing the need for animal testing while increasing efficiency in a pesticide regulatory setting: Lessons from the EPA Office of Pesticide Programs' Hazard and Science Policy Council. , 2019, Regulatory toxicology and pharmacology : RTP.

[17]  Nicole Kleinstreuer,et al.  Systems Modeling of Developmental Vascular Toxicity. , 2019, Current opinion in toxicology.

[18]  Alan R. Boobis,et al.  Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans. , 2019, Regulatory toxicology and pharmacology : RTP.

[19]  W. Casey,et al.  Reflections on the progress towards non-animal methods for acute toxicity testing of chemicals. , 2019, Regulatory toxicology and pharmacology : RTP.

[20]  Alan Raybould,et al.  A simple problem formulation framework to create the right solution to the right problem. , 2019, Regulatory toxicology and pharmacology : RTP.

[21]  Martyn L. Chilton,et al.  A defined approach for predicting skin sensitisation hazard and potency based on the guided integration of in silico, in chemico and in vitro data using exclusion criteria , 2019, Regulatory toxicology and pharmacology : RTP.

[22]  H. Spielmann.  Progress in Eliminating One-Year Dog Studies for the Safety Assessment of Pesticides , 2018, Alternatives to Animal Testing.

[23]  David Allen,et al.  Pathway-based predictive approaches for non-animal assessment of acute inhalation toxicity. , 2018, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  J. Goodman,et al.  Goodbye to the bioassay. , 2018, Toxicology research.

[25]  A. Piersma,et al.  Rethinking developmental toxicity testing: Evolution or revolution? , 2018, Birth defects research.

[26]  G. Horgan,et al.  An evaluation of the fixed concentration procedure for assessment of acute inhalation toxicity , 2018, Regulatory toxicology and pharmacology : RTP.

[27]  Marianna Gaça,et al.  Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report. , 2018, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  Catherine Mahony,et al.  The future trajectory of adverse outcome pathways: a commentary , 2018, Archives of Toxicology.

[29]  N. Katsanis,et al.  Temperature-activated ion channels in neural crest cells confer maternal fever–associated birth defects , 2017, Science Signaling.

[30]  J. Strickland,et al.  Biometrical evaluation of the performance of the revised OECD Test Guideline 402 for assessing acute dermal toxicity , 2017, Regulatory toxicology and pharmacology : RTP.

[31]  R. Pieters,et al.  Application of Caenorhabditis elegans (nematode) and Danio rerio embryo (zebrafish) as model systems to screen for developmental and reproductive toxicity of Piperazine compounds. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.

[32]  A. Woollard,et al.  An enhanced C. elegans based platform for toxicity assessment , 2017, Scientific Reports.

[33]  Jan Willem van der Laan,et al.  Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties , 2016, Front. Med..

[34]  Peter Kasper,et al.  Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties , 2016, Critical reviews in toxicology.

[35]  Julieta M. Panzica-Kelly,et al.  A Developmental Toxicology Assay Platform for Screening Teratogenic Liability of Pharmaceutical Compounds. , 2016, Birth defects research. Part B, Developmental and reproductive toxicology.

[36]  Ivan Rusyn,et al.  Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis , 2015, Environmental health perspectives.

[37]  Hajime Kojima,et al.  A global initiative to refine acute inhalation studies through the use of 'evident toxicity' as an endpoint: Towards adoption of the fixed concentration procedure. , 2015, Regulatory toxicology and pharmacology : RTP.

[38]  Melvin E Andersen,et al.  Adverse Outcome Pathways can drive non-animal approaches for safety assessment , 2015, Journal of applied toxicology : JAT.

[39]  Neil Spooner,et al.  Reducing pre-clinical blood volumes for toxicokinetics: toxicologists, pathologists and bioanalysts unite. , 2014, Bioanalysis.

[40]  Rick Clayton,et al.  Advancing the 3Rs in regulatory toxicology - Carcinogenicity testing: Scope for harmonisation and advancing the 3Rs in regulated sectors of the European Union. , 2014, Regulatory toxicology and pharmacology : RTP.

[41]  Julieta M. Panzica-Kelly,et al.  Fishing for teratogens: a consortium effort for a harmonized zebrafish developmental toxicology assay. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  R. Burrier,et al.  Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening. , 2013, Birth defects research. Part B, Developmental and reproductive toxicology.

[43]  Julieta M. Panzica-Kelly,et al.  Establishment of a molecular embryonic stem cell developmental toxicity assay. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  Julieta M. Panzica-Kelly,et al.  Inter-laboratory assessment of a harmonized zebrafish developmental toxicology assay - progress report on phase I. , 2012, Reproductive toxicology.

[45]  Daniel Morton,et al.  An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing , 2011, Toxicologic pathology.

[46]  Richard W. Lewis,et al.  The mouse carcinogenicity study is no longer a scientifically justifiable core data requirement for the safety assessment of pesticides , 2010, Critical reviews in toxicology.

[47]  Ronald N. Hines,et al.  A Tiered Approach to Life Stages Testing for Agricultural Chemical Safety Assessment , 2006 .